Profile: Celera mainly develops and manufactures molecular diagnostic products that are used by hospitals & other clinical laboratories to detect, characterize, monitor & select treatment for disease. Our viroseq HIV-1 system is used in detecting HIV genomic mutations that confer resistance to specific types of antiretroviral drugs & as an aid in monitoring & treating HIV infection. This system can be used for managing therapy changes in HIV-1 infected patients whose drug regimen has failed and in HIV-1 infected individuals at initial presentation, before starting treatment. Our cystic fibrosis genotyping assay is a qualitative in vitro diagnostic device used to genotype a panel of mutations and variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene in genomic DNA isolated from human whole blood specimens.